SE0100569D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE0100569D0 SE0100569D0 SE0100569A SE0100569A SE0100569D0 SE 0100569 D0 SE0100569 D0 SE 0100569D0 SE 0100569 A SE0100569 A SE 0100569A SE 0100569 A SE0100569 A SE 0100569A SE 0100569 D0 SE0100569 D0 SE 0100569D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- active compounds
- preparation
- compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100569A SE0100569D0 (sv) | 2001-02-20 | 2001-02-20 | New compounds |
PL02363393A PL363393A1 (en) | 2001-02-20 | 2002-02-18 | New pyrimidine compounds |
EEP200300400A EE200300400A (et) | 2001-02-20 | 2002-02-18 | Pürimidiiniühendid, nende valmistamismeetod ning kasutamine |
JP2002565540A JP4475869B2 (ja) | 2001-02-20 | 2002-02-18 | 新規なピリミジン化合物 |
MXPA03007320A MXPA03007320A (es) | 2001-02-20 | 2002-02-18 | Nuevos compuestos de pirimidina. |
SK1025-2003A SK10252003A3 (sk) | 2001-02-20 | 2002-02-18 | Pyrimidínové zlúčeniny |
IL15678102A IL156781A0 (en) | 2001-02-20 | 2002-02-18 | (diazolo-pyridinyl)-pyrimidines for use in teatment of cns disorders and diabetes |
CA002434648A CA2434648A1 (en) | 2001-02-20 | 2002-02-18 | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
CNB028052471A CN1294131C (zh) | 2001-02-20 | 2002-02-18 | 新嘧啶化合物 |
KR10-2003-7010874A KR20030084935A (ko) | 2001-02-20 | 2002-02-18 | Cns 장애 및 당뇨병의 치료에 사용하기 위한(디아졸로-피리디닐)-피리미딘 |
CZ20032235A CZ20032235A3 (cs) | 2001-02-20 | 2002-02-18 | Nové pyrimidinové sloučeniny |
NZ526783A NZ526783A (en) | 2001-02-20 | 2002-02-18 | (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes |
RU2003121307/04A RU2003121307A (ru) | 2001-02-20 | 2002-02-18 | (диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета |
US10/468,604 US7345050B2 (en) | 2001-02-20 | 2002-02-18 | Pyrimidine compounds |
HU0303254A HUP0303254A2 (hu) | 2001-02-20 | 2002-02-18 | Új pirimidinvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
PCT/SE2002/000271 WO2002065979A2 (en) | 2001-02-20 | 2002-02-18 | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
BR0206935-0A BR0206935A (pt) | 2001-02-20 | 2002-02-18 | Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto |
EP02711620A EP1373266A2 (en) | 2001-02-20 | 2002-02-18 | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
IS6868A IS6868A (is) | 2001-02-20 | 2003-07-08 | Ný pýrimidínefnasambönd |
BG108070A BG108070A (bg) | 2001-02-20 | 2003-08-07 | Нови пиримидинови съединения |
ZA200306171A ZA200306171B (en) | 2001-02-20 | 2003-08-08 | (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes. |
NO20033679A NO20033679D0 (no) | 2001-02-20 | 2003-08-19 | Nye pyrimidinforbindelser |
HK05102865A HK1070071A1 (en) | 2001-02-20 | 2005-04-06 | New pyrimidine compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100569A SE0100569D0 (sv) | 2001-02-20 | 2001-02-20 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100569D0 true SE0100569D0 (sv) | 2001-02-20 |
Family
ID=20283059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100569A SE0100569D0 (sv) | 2001-02-20 | 2001-02-20 | New compounds |
Country Status (23)
Country | Link |
---|---|
US (1) | US7345050B2 (xx) |
EP (1) | EP1373266A2 (xx) |
JP (1) | JP4475869B2 (xx) |
KR (1) | KR20030084935A (xx) |
CN (1) | CN1294131C (xx) |
BG (1) | BG108070A (xx) |
BR (1) | BR0206935A (xx) |
CA (1) | CA2434648A1 (xx) |
CZ (1) | CZ20032235A3 (xx) |
EE (1) | EE200300400A (xx) |
HK (1) | HK1070071A1 (xx) |
HU (1) | HUP0303254A2 (xx) |
IL (1) | IL156781A0 (xx) |
IS (1) | IS6868A (xx) |
MX (1) | MXPA03007320A (xx) |
NO (1) | NO20033679D0 (xx) |
NZ (1) | NZ526783A (xx) |
PL (1) | PL363393A1 (xx) |
RU (1) | RU2003121307A (xx) |
SE (1) | SE0100569D0 (xx) |
SK (1) | SK10252003A3 (xx) |
WO (1) | WO2002065979A2 (xx) |
ZA (1) | ZA200306171B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
AU2003208479A1 (en) | 2002-03-09 | 2003-09-22 | Astrazeneca Ab | 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity |
GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
TW200528101A (en) | 2004-02-03 | 2005-09-01 | Astrazeneca Ab | Chemical compounds |
US20080207594A1 (en) | 2005-05-04 | 2008-08-28 | Davelogen Aktiengesellschaft | Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders |
UY29827A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones |
WO2007040436A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
DE602006021645D1 (de) | 2005-11-15 | 2011-06-09 | Array Biopharma Inc | Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten |
TW200811169A (en) * | 2006-05-26 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
JP2010518014A (ja) * | 2007-01-31 | 2010-05-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用な2−アミノピリジン誘導体 |
AR069501A1 (es) | 2007-11-30 | 2010-01-27 | Genentech Inc | Anticuerpos anti- vegf (factor de crecimiento endotelial vascular) |
ES2524259T3 (es) * | 2008-03-24 | 2014-12-04 | Novartis Ag | Inhibidores de metaloproteinasa de matriz a base de arilsulfonamida |
US8344018B2 (en) | 2008-07-14 | 2013-01-01 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
US8134000B2 (en) | 2008-07-14 | 2012-03-13 | Gilead Sciences, Inc. | Imidazolyl pyrimidine inhibitor compounds |
US8124764B2 (en) | 2008-07-14 | 2012-02-28 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitor compounds |
US8088771B2 (en) | 2008-07-28 | 2012-01-03 | Gilead Sciences, Inc. | Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
US9101645B2 (en) | 2008-10-22 | 2015-08-11 | Genentech, Inc. | Modulation of axon degeneration |
CA2761064A1 (en) | 2009-04-15 | 2010-10-21 | Astrazeneca Ab | Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease |
NZ596783A (en) | 2009-06-08 | 2014-01-31 | Gilead Sciences Inc | Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds |
JP5586692B2 (ja) | 2009-06-08 | 2014-09-10 | ギリアード サイエンシーズ, インコーポレイテッド | アルカノイルアミノベンズアミドアニリンhdacインヒビター化合物 |
KR102414221B1 (ko) | 2020-08-04 | 2022-06-27 | 서울시립대학교 산학협력단 | 열전 소자 어셈블리, 이의 제조 방법, 및 이를 포함하는 열전 모듈 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE29032E (en) * | 1969-06-12 | 1976-11-09 | Riker Laboratories, Inc. | 3-Benzoylfluoro-methanesulfonanilides |
FR2179493A1 (en) * | 1972-04-10 | 1973-11-23 | Roussel Uclaf | Amino benzhydrols - choleretics anticonvulsants sedatives and barbiturate potentiators |
DE3042466A1 (de) * | 1980-11-11 | 1982-06-16 | A. Nattermann & Cie GmbH, 5000 Köln | N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
TW225528B (xx) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
-
2001
- 2001-02-20 SE SE0100569A patent/SE0100569D0/xx unknown
-
2002
- 2002-02-18 BR BR0206935-0A patent/BR0206935A/pt not_active IP Right Cessation
- 2002-02-18 US US10/468,604 patent/US7345050B2/en not_active Expired - Fee Related
- 2002-02-18 MX MXPA03007320A patent/MXPA03007320A/es unknown
- 2002-02-18 NZ NZ526783A patent/NZ526783A/en unknown
- 2002-02-18 KR KR10-2003-7010874A patent/KR20030084935A/ko not_active Application Discontinuation
- 2002-02-18 EP EP02711620A patent/EP1373266A2/en not_active Withdrawn
- 2002-02-18 CZ CZ20032235A patent/CZ20032235A3/cs unknown
- 2002-02-18 EE EEP200300400A patent/EE200300400A/xx unknown
- 2002-02-18 JP JP2002565540A patent/JP4475869B2/ja not_active Expired - Lifetime
- 2002-02-18 WO PCT/SE2002/000271 patent/WO2002065979A2/en active IP Right Grant
- 2002-02-18 IL IL15678102A patent/IL156781A0/xx unknown
- 2002-02-18 SK SK1025-2003A patent/SK10252003A3/sk unknown
- 2002-02-18 HU HU0303254A patent/HUP0303254A2/hu unknown
- 2002-02-18 CN CNB028052471A patent/CN1294131C/zh not_active Expired - Fee Related
- 2002-02-18 CA CA002434648A patent/CA2434648A1/en not_active Abandoned
- 2002-02-18 RU RU2003121307/04A patent/RU2003121307A/ru not_active Application Discontinuation
- 2002-02-18 PL PL02363393A patent/PL363393A1/xx not_active Application Discontinuation
-
2003
- 2003-07-08 IS IS6868A patent/IS6868A/is unknown
- 2003-08-07 BG BG108070A patent/BG108070A/bg unknown
- 2003-08-08 ZA ZA200306171A patent/ZA200306171B/xx unknown
- 2003-08-19 NO NO20033679A patent/NO20033679D0/no unknown
-
2005
- 2005-04-06 HK HK05102865A patent/HK1070071A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2004527486A (ja) | 2004-09-09 |
EP1373266A2 (en) | 2004-01-02 |
CN1537112A (zh) | 2004-10-13 |
BR0206935A (pt) | 2004-06-29 |
NO20033679L (no) | 2003-08-19 |
CZ20032235A3 (cs) | 2004-01-14 |
BG108070A (bg) | 2004-07-30 |
WO2002065979A3 (en) | 2003-02-20 |
KR20030084935A (ko) | 2003-11-01 |
EE200300400A (et) | 2003-12-15 |
NO20033679D0 (no) | 2003-08-19 |
US7345050B2 (en) | 2008-03-18 |
PL363393A1 (en) | 2004-11-15 |
WO2002065979A2 (en) | 2002-08-29 |
US20040077642A1 (en) | 2004-04-22 |
JP4475869B2 (ja) | 2010-06-09 |
SK10252003A3 (sk) | 2004-02-03 |
CA2434648A1 (en) | 2002-08-29 |
IL156781A0 (en) | 2004-02-08 |
HUP0303254A2 (hu) | 2004-01-28 |
IS6868A (is) | 2003-07-08 |
RU2003121307A (ru) | 2005-02-27 |
HK1070071A1 (en) | 2005-06-10 |
MXPA03007320A (es) | 2003-12-04 |
ZA200306171B (en) | 2004-11-08 |
NZ526783A (en) | 2005-04-29 |
CN1294131C (zh) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0200979D0 (sv) | New compounds | |
SE0100569D0 (sv) | New compounds | |
TW200745111A (en) | New compounds | |
ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
TW200510375A (en) | New compounds | |
UY27368A1 (es) | Nuevos compuestos | |
SE0102439D0 (sv) | New compounds | |
ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
BR0211473A (pt) | Novos compostos | |
EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
TW200606164A (en) | New compounds | |
GB0003154D0 (en) | Novel compounds | |
MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
BR0211472A (pt) | Novos compostos | |
NO20024005D0 (no) | Pteridinforbindelser for behandling av psoriasis | |
SE9904508D0 (sv) | New compounds | |
TW200800984A (en) | New compounds | |
SE0102440D0 (sv) | New compound | |
SE0102055D0 (sv) | New Compounds | |
SE0104331D0 (sv) | Novel compounds | |
SE0101322D0 (sv) | Novel compounds | |
ATE253359T1 (de) | Antithrombotische mittel | |
SE0102057D0 (sv) | New Salts I | |
IT1307786B1 (it) | Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali. | |
ATE286395T1 (de) | Antithrombotische mittel |